[{"Assets_0_FY_USD":422202000.0,"CommonStockSharesConverted_0_FY_shares":35915119.0,"CommonStockSharesOutstanding_0_FY_shares":35915119.0,"EarningsPerShareBasic_1_FY_USD":-0.58,"EarningsPerShareBasic_4_FY_USD":-2.99,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-57757000.0,"NetIncomeLossConverted_1_FY_USD":-20959000.0,"NetIncomeLossConverted_4_FY_USD":-72131000.0,"StockholdersEquity_0_FY_USD":404351000.0,"Ticker":"TPTX","CIK":"1595893","name":"TURNING POINT THERAPEUTICS, INC.","OfficialName":"Turning Point Therapeutics Inc. Common Stock","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1579986704.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200318"}]